Reducing human suffering by detecting cancer earlier with patented technology
BioCurex's RECAF(tm) marker is found in all types of major cancers

AGORACOM News Flash

If you're not following the AGORACOM Blog, you are missing great and informative market posts such as my weekly small-cap market talk with Peter Grandich.

Listen to this week's show that discusses the significance of this week's events on small-cap markets, including sovereign debt, the $USD Index and falling gold prices.

Message: Is selling the company an option?

Banned_profile
This user has been banned for violating Agoracom's Six Rules of Use

Is selling the company an option?

posted on Nov 25, 08 05:24AM

Dr. Moro. In the latest filing, the current cash position is $90,000 which is not enough to continue current operations. If you cannot obtain more funding to pay the loan, will the lack of money cause the company be sold? Does the hedge fund have any lien on the latest patents or any additional patent grants? Does the hedge fund have any lien on BioCurex China?

New Message

Please login to post a reply

AGORACOM Quick Tips

AGORACOM 100 - The Top 100 Small Caps ... Find Your Next Investment

President's D.D.

New feature: Hub Presidents can add important links here.

Stock Quote